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Background/aims: Breast cancer is the most common tumor in women and the first cause of death for malignancy
in the female population. Bile ducts are not among the common sites of metastasis from breast cancer; few cases of
obstructive jaundice due to metastatic breast cancer have been described in the literature and they mostly resulted
from widespread liver metastases that eventually involved the bile ducts. We report an exceptional case of metastatic
infiltration of the extrahepatic bile ducts in absence of liver metastases.
Case presentation: A 56-year-old woman who had undergone a right mastectomy 13 years earlier due to infiltrating
ductal breast cancer and had remained tumor free, presented at a follow-up examination with obstructive jaundice.
Imaging (computed tomography, magnetic resonance and endoscopic retrograde cholangiopancreatography) scans
showed features that were suggestive of a primary tumor of the extrahepatic bile duct. At surgery, the intraoperative
findings were also those of a tumor of the bile duct, however, an histological examination showed no evidence of
malignancy in the mucosa, but did shown an infiltration of the external wall from adenocarcinoma.
Immunohistochemistry analysis demonstrated that the tumor was metastatic breast cancer.
Conclusions: Indeterminate stenosis of the extrahepatic bile ducts should be examined with suspicion in women with
a history of breast cancer, and bile duct metastases are to be considered among the possible diagnoses. A differential
diagnosis from cholangiocarcinoma is of paramount importance and mainly relies on pathology.
Keywords: Bile duct tumors, Breast cancer, Breast cancer metastasesBackground
Strictures of the proximal tract of the extrahepatic bile
ducts are caused by hilar cholangiocellular carcinoma in
over 80% of cases. Other possible causes of proximal
biliary obstruction are inflammatory and stone disease,
sclerosing cholangitis or, more rarely, spread from gall-
bladder cancer [1].
Despite all improvements and new developments in
available diagnostic tools, a significant proportion of bile
duct stenoses remain indeterminate before surgery. While
it is reported that 13 to 24% of the presumed diagnoses of
hilar cholangiocarcinoma are not confirmed at surgery,
where they are found to be benign [2], the possibility of a* Correspondence: vivarelli63@libero.it
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generally taken into account.
Breast cancer is the most common malignancy in
women, accounting for 29% of all female tumors [3]; it is
the main cause of death from cancer in females and the
second in the general population, after lung cancer [4,5].
In 10% of the cases distant metastases are already
present at the time of the diagnosis [6]. Breast cancer
metastases occur through contiguous, lymphatic and
hematogenous spread. Common sites of metastasis include
bone, lung, lymph nodes, liver and brain [7]. Widespread
liver metastases that compress or infiltrate the bile ducts
can sometimes cause obstructive jaundice, whilst a direct
metastatic involvement of the extrahepatic bile ducts in
absence of hepatic lesions is exceptional.
We report a case of obstructive jaundice due to a
metastatic deposit from breast cancer on the outer layer
of the extrahepatic bile ducts that mimicked a hilar. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to ascertain whether such a case had ever been reported
in the past.
Case presentation
In February 2013 a 56-year-old female was referred to our
institution due to obstructive jaundice. Laboratory tests
showed increased aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) serum levels (206 UI/ml
and 656 UI/ml, respectively), and total and conjugated
hyperbilirubinemia levels (9.5 mg/dl and 8.1 mg/dl,
respectively). Tumor markers, namely carcinoembryonic
antigen (CEA), cancer antigen 19-9 (CA 19-9), alpha-
fetoprotein (AFP), cancer antigen15-3 (CA 15-3) and
cancer antigen 125 (CA 125) were within normal ranges.
An abdominal ultrasound (US) and computed tomog-
raphy (CT) scan showed severe non-lithiasic hydropic
gallbladder with intra- and extrahepatic dilatation of the
biliary tree and thickening of the common bile duct wall.
There was no evidence of growth in the head of pancreas,
liver or peribiliary tissue. Magnetic resonance imaging
(MRI) showed a 2-cm stenosis of the middle portion of
the common bile duct, while the distal tract was appar-
ently disease-free (Figure 1).
Endoscopic retrograde cholangiopancreatography (ERCP)
confirmed the presence of marked dilatation of the biliary
tree that started from the proximal portion of the common
bile duct and involved the confluence of the hepatic ducts.
Cytology of the brushing from the bile duct showed no
malignant cells.
In the patient’s past medical history there was a right
radical mastectomy with axillary lymph node dissection
for breast cancer performed 13 years earlier. At that time
there was no evidence of distant metastasis. Pathology ofFigure 1 Magnetic resonance imaging showing the stenosis of
the middle portion of the common bile duct and the dilatation
of intra- and extra-hepatic biliary tree.the primary breast cancer revealed a 2-cm invasive ductal
AJCC grade 2 carcinoma. Nipple, surgical borders and
all of the 16 lymph nodes removed were free from
malignancy. Essays for hormonal receptors were weakly
positive, with estrogen receptors at 4.2 fmol/ml and
progesterone receptors at 1.5 fmol/ml; a human epidermal
growth factor receptor 2 (HER2)/Ki-67 test was not
performed. After a mastectomy, the patient received
adjuvant chemotherapy based on six cycles of CMF
regimen (cyclophosphamide 600 mg/m2, methotrexate
40 mg/m2, 5-fluorouracil 600 mg/m2 intravenously on
days one to eight, every four weeks), and was treated
for the following three years with adjuvant hormonal
therapy based on luteinizing hormone-releasing hormone
(LH-RH) antagonist (triptorelin) only. Regular oncological
follow-up were instituted and no recurrence had been
detected through the years.
As the presumed diagnosis was that of primary bile
duct tumor, in March 2013, the patient underwent a
laparotomy (Figure 2). In addition to the mentioned
abdominal imaging, the preoperative work-up included a
chest X-ray that showed no lesion.Figure 2 Intraoperative image: isolation of the biliary and
vascular elements of the hepatic hilum. Note the thickened wall
of the common (arrow) and right/left bile ducts. CBD: common bile
duct; LHA: left hepatic artery; RHA: right hepatic artery, RHD: right
hepatic duct; RPV: right branch of the portal vein.
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tumor spread. A retropancreatic lymph node was removed
and sent for extemporaneous histological examination
which showed the presence of metastatic adenocarcinoma;
it was not possible to define the origin of the adenocarcin-
oma on the frozen section. The bile duct was thickened
and of hard consistency at palpation up to the confluence
of the main hepatic ducts. After a cholecystectomy, the
whole extrahepatic biliary tract was resected, including
both right and left ducts. An extemporaneous histological
examination of the resected biliary ducts showed an
absence of malignancy in the mucosa, while there was
infiltration of the external wall from the adenocarcin-
oma, with cells disposed in honeycombs. Because of the
undetermined origin of the malignancy and its wide
extension, it was decided to avoid any hepatic or pan-
creatic resection and the bile drainage was restored
through a double hepaticojejunostomy. The patient’s
postoperative course was uneventful, with rapid return
of normal liver function, and the patient was discharged
after seven days.
The definitive pathological study described solid hon-
eycombs of malignant epithelial cells, localised only in
the external side of the biliary duct wall, while the
mucosa was free from infiltration (Figure 3). Several
images of perivascular and perineural invasion were
described. Lymph nodes were extensively metastatic. An
immunohistochemistry analysis of the tumor in the bile
duct and the lymph nodes showed high proliferative
activity (Mib-1 > 32%); cells were strongly positive for
estrogen receptors (90%) and also positive for progesterone
receptors (20%), mammaglobin and cytokeratin-7 (CK-7).
Staining was negative for HER2/neu and cytokeratin-20
(CK-20) markers. These findings were in keeping with
hormone receptor positive, HER2/neu negative metastatic
breast cancer.
The patient was referred to an oncologist who decided
on a treatment course of denosumab (120 mg subcutane-Figure 3 Hematoxylin and eosin stain from an optical microscope at
the bile duct wall. In (a), the whole thickness of the wall is included in th
the right side of the histological specimen, and it is covered by normal mu
perivascular and intravascular (arrow) invasion of metastatic cells are shownously every four weeks) and letrozole (2.5 mg per day),
which are still ongoing and well tolerated. At present she is
alive and well and there is no evidence of relapse in the
liver or bile ducts.
Conclusions
In the presence of a bile duct stricture at the hepatic
hilum it can be difficult to establish a diagnosis prior to
surgery, even when several investigations such as serum
tumor markers, cholangiole MRI, ERCP with intraductal
brushing, endoscopic ultrasound and, where available,
cholangioscopy are combined. On the other hand, the
fact that cholangiocellular carcinoma is the most common
cause of those strictures justifies a surgical approach,
whereas a malignancy cannot be excluded.
Virtually, every site of the human body can be targeted
by hematogenous spread of breast cancer, however,
metastases to the digestive tract, the kidneys and retro-
peritoneal organs have been only occasionally reported.
Metastatic breast cancer can cause obstructive jaundice
when multiple liver lesions are present, the bile duct is
compressed by enlarged lymph nodes or, more rarely,
when the head of the pancreas is targeted. The biliary
tract is very rarely affected by metastases in general, and
in these cases, colorectal cancer is the most frequent
malignancy involved [8]. Isolated breast cancer metas-
tasis to the biliary tract, gallbladder and Vater ampulla
are exceptional. By reviewing the literature, we were
able to find only 27 cases of extrahepatic biliary tract
metastasis from breast cancer (Table 1) [9-19]. Of these
27 cases, four were reported in publications that were
not available in full (Feliu Villaro et al. [10] whose art-
icle is only available in Spanish, and Rabin and Richter
[16] as the journal is not available in the Italian library
system.
In the largest series reported (reported in the 1970s),
Popp et al. [15] described seven cases of women who
underwent surgery to relieve a biliary obstruction fromlow magnification (40×, a) and high magnification (400×, b) of
e view field; as specified in the image, the lumen of the bile duct is on
cosa. In (b) there is a detail of the external side of the bile duct wall:
.
Table 1 Reported cases of metastatic breast cancer involving the bile ducts
Author Number of cases Reported localisation Treatment
Popp et al. 1979 [15] 7 Extrahepatic lymph nodes, wall of
the common bile duct (1 case)
Radical and palliative surgery, transhepatic
drainage, radiation, chemotherapy
Rabin and Richter
et al. 1979 [16]
3 Undetermined Undetermined
Kopelson et al. 1980 [12] 6 Extrahepatic duct Radical and palliative surgery, radiation, chemotherapy
Engel et al. 1980 [9] 2 Extrahepatic duct, lymph nodes Biliary tract resection and choledochojejunostomy
Franco et al. 1987 [11] 2 Proximal bile duct, bifurcation. Bile duct resection, double choledochojejunostomy,
cholecystectomy
Pappo et al. 1991 [14] 1 Extrahepatic, intra
and extraluminal
Bile duct resection, choledochojejunostomy, cholecystectomy
Feliu Villaró et al. 1995 [10] 1 Extrahepatic intraluminal Undetermined
Papo et al. 1996 [13] 1 Extrahepatic intraluminal Biliary tract resection and choledochojejunostomy
Titus et al. 1997 [19] 1 Distal bile duct Pancreaticoduodenectomy
Stoeckler et al. 2007 [18] 1 Distal bile duct Pancreaticoduodenectomy
Rego et al. 2009 [17] 2 Ampulla of Vater, intraluminal Surgery, observation
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from the diagnosis of the primary tumor. The pre-operative
work-up was mainly based on ERCP and percutaneous
transhepatic cholangiography (PTC) as CT and MRI scans
were not available at those times, therefore the diagnosis
of metastatic involvement of the bile duct was considered
unlikely before surgery. At surgery, two patients had
liver metastases and, in six of the seven cases, bile duct
compression from lymph-node metastases was the cause
of the obstruction. Eventually only one patient had direct
metastasis to the bile duct [15]. In the second largest
series from Kopelson et al. (also reported in the 1970s),
the extrahepatic biliary system was reported as the ‘ini-
tial site’ metastasis, however, no further details were
provided [12].
In an article published by Engel et al. in 1980, two
cases were described; the bile duct was compressed by
an intraperitoneal mass in one case and by enlarged
metastatic lymph nodes in the other [9]. [11] reported
two cases of metastases of the proximal bile duct in
women whose breast cancer had been diagnosed six and
eight years earlier. In the first of these cases the tumor
was mainly located in the lymphatic ducts within the
bile duct wall while in the other it was transmural [11].
Differently from the case herein described, in the reports
from Pappo et al. [14] and Papo et al. [13] the tumor
involved the lumen of the bile duct, while in the cases
described by Titus et al. [19] and Stoeckler et al. [18] it
originated from the Ampulla of Vater and infiltrated the
bile duct wall.
A permanent feature of all the reports available in
the literature is that the diagnosis was not achieved
nor suspected before surgery, with the only exception
being Rego et al. who reported two cases where the
bile duct was involved in the periampullary area andthe endoscopic biopsy allowed a preoperative diagnosis
[17]. Similarly to what we observed, in the majority of the
cases there was a long interval between the diagnosis of
the primary tumor and the development of metastases
affecting the biliary tract; this timing can make it hard to
suspect a relationship between the breast cancer and the
biliary disease.
As far as we know, the present case is unique as only
the external side of the bile ducts was involved by the
tumor, which made it impossible to reach a diagnosis
before the specimen was removed. However, the absence
of malignancy in the mucosal side of the bile ducts and
the peculiar disposition of the tumor cells in external
wall were not in keeping with the diagnosis of cholangio-
cellular carcinoma, and therefore contraindicated more
aggressive surgery involving hepatic resection.
The present report provides some evidence that me-
tastases from breast cancer can target the extrahepatic
bile ducts in the absence of liver involvement, and the
invasion of the bile duct wall can also take place without
evidence of disease in the lumen or the mucosa of the
duct, thus making the preoperative diagnosis particularly
difficult. In patients with a history of breast cancer, the
possibility of a biliary localisation of metastatic disease
should be considered in the differential diagnosis of
obstructive jaundice due to a bile duct stenosis whose
origin is unclear. In similar circumstances the first goal
that can be achieved is to rule out the diagnosis of
cholangiocellular carcinoma to avoid unnecessary demo-
lition of the hepatic parenchyma. At surgery, frozen
sections should be obtained and the pathologist should
be informed of the medical history of breast cancer. In
cases where the histological features are not typical of
cholangiocellular carcinoma, hepatic resection should be
avoided.
Coletta et al. World Journal of Surgical Oncology 2014, 12:384 Page 5 of 5
http://www.wjso.com/content/12/1/384Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
AFP: alpha-fetoprotein; ALT: alanine aminotransferase; AST: aspartate
aminotransferase; CA19-9: cancer antigen; CA15-3: cancer antigen; CA 125: cancer
antigen; CEA: carcinoembryonic antigen; CK-7, CK-20: cytokeratin-7-20;
CT: computed tomography; ERCP: endoscopic retrograde
cholangiopancreatography; HER2: human epidermal growth factor receptor 2;
LH-RH: luteinizing hormone releasing hormone; MRI: magnetic resonance
imaging; PTC: percutaneous trans hepatic cholangiography; US: ultrasound.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CM and VP wrote the manuscript. MR, MF and PM revised the manuscript.
VM conceived the study. All authors read and approved the final manuscript.
Author details
1Department of Gastroenterology and Transplantation, Hepatobiliary and
Abdominal Transplantation Surgery, Marche Polytechnic University, AOU
Ospedali Riuniti, via Conca 71, 60129 Ancona, Italy. 2Department of Medicine,
Oncology Clinic, Marche Polytechnic University, AOU Ospedali Riuniti, via
Conca 71, 60129 Ancona, Italy.
Received: 22 September 2014 Accepted: 18 November 2014
Published: 16 December 2014
References
1. Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM: Hilar
cholangiocarcinoma: diagnosis, treatment options, and management.
Hepatobiliary Surg Nutr 2014, 3:18–34.
2. Victor DW, Sherman S, Karakan T, Khashab MA: Current endoscopic
approach to indeterminate biliary strictures. World J Gastroenterol 2012,
18:6197–6205.
3. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ,
Edwards BK, Berry DA: The decrease in breast-cancer incidence in 2003 in
the United States. N Engl J Med 2007, 356:1670–1674.
4. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence
and mortality in Europe in 2008. Eur J Cancer 2010, 46:765–781.
5. Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, Palli D, Gail MH:
Risk factor modification and projections of absolute breast cancer risk.
J Natl Cancer Inst 2011, 103:1037–1048.
6. Oratz R: Management of metastatic breast cancer. In Breast Cancer.
Chapter 32,2nd edition. Churchill Livingstone: Elsevier; 2005:595–689.
7. Markelov A, Taheri H, Vunnamadala K, Ibrahim G: Biliary dyskinesia as a
rare presentation of metastatic breast carcinoma of the gallbladder: a
case report. Case Rep Pathol 2011, 2011:806570.
8. Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN:
Mimics of cholangiocarcinoma: spectrum of disease. Radiographics 2008,
28:1115–1129.
9. Engel JJ, Trujillo Y, Spellberg M: Metastatic carcinoma of the breast: a
cause of obstructive jaundice. Gastroenterology 1980, 78:132–135.
10. Feliu Villaro F, Luengo Rodriguez de Ledesma L, Gomez Sugranes JR,
Castellote Caixal M, Ros López S, García Rubio B: Obstructive jaundice due
to the intraluminal biliary metastasis of a breast carcinoma. Rev Esp
Enferm Dig 1995, 87:482–483.
11. Franco D, Martin B, Smadja C, Szekely AM, Rougier P: Biliary metastases of
breast carcinoma. The case for resection. Cancer 1987, 60:96–99.
12. Kopelson G, Chu AM, Doucette JA, Gunderson LL: Extra-hepatic biliary
tract metastases from breast cancer. Int J Radiat Oncol Biol Phys 1980,
6:497–504.
13. Papo M, Fernandez J, Quer JC, Sirvent JJ, Richart C: Metastatic breast
carcinoma presenting as obstructive jaundice. Am J Gastroenterol 1996,
91:2240–2241.14. Pappo I, Feigin E, Uziely B, Amir G: Biliary and pancreatic metastases of
breast carcinoma: is surgical palliation indicated? J Surg Oncol 1991,
46:211–214.
15. Popp JW Jr, Schapiro RH, Warshaw AL: Extrahepatic biliary obstruction
caused by metastatic breast carcinoma. Ann Intern Med 1979, 91:568–571.
16. Rabin MS, Richter IA: Metastatic breast carcinoma presenting as
obstructive jaundice. A report of 3 cases. S Afr Med J 1979, 55:388–390.
17. Rego RF, Atiq M, Velchala N, Nevin D, McElreath DP, McKnight WD, Aduli F:
Ampullary metastasis from breast cancer: an unusual finding. Endoscopy
2009, 41(Suppl 2):E278–E279.
18. Stoeckler F, Hagmuller E, Rumpelt HJ, Weickert U: A rare cause of distal
bile duct stenosis. J Gastrointest Cancer 2007, 38:157–159.
19. Titus AS, Baron TH, Listinsky CM, Vickers SM: Solitary breast metastasis to
the ampulla and distal common bile duct. Am Surg 1997, 63:512–515.
doi:10.1186/1477-7819-12-384
Cite this article as: Coletta et al.: Metastatic breast cancer mimicking a
hilar cholangiocarcinoma: case report and review of the literature. World
Journal of Surgical Oncology 2014 12:384.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
